


OregonTherapeutics Revenue
Pharmaceutical Manufacturing • Paris, Île-de-France, France • 1-10 Employees
OregonTherapeutics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at OregonTherapeutics
Marc-Henry Pitty
CEO
Company overview
| Headquarters | 3 rue du colonel Moll, Paris, Île de France 75017, FR |
| Phone number | +3306010343 |
| Website | |
| NAICS | 3254 |
| Keywords | Biotechnology, Pharmaceuticals, Oncology, Biology |
| Founded | 2014 |
| Employees | 1-10 |
| Socials |
About OregonTherapeutics
OregonTherapeutics is developing XCE853 : Disruptive targeted therapy “First in class” & “Best in class” in oncology. XCE853 is based on an innovative and unique mechanism of action : Inhibition of protein disulfide isomerase. OregonTherapeutics first objective is to bring XCE853 into clinical trial (phase 1) for the treatment of cancer within 2 years. Based on the scientific rationale, the priority indication is advanced pancreatic cancer. Potential additional indications are ovarian, livers, and head & neck cancers.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
OregonTherapeutics has 1 employees across 1 departments.
Departments
Number of employees
OregonTherapeutics Tech Stack
Discover the technologies and tools that power OregonTherapeutics's digital infrastructure, from frameworks to analytics platforms.
Web servers
Cookie compliance
WordPress themes
JavaScript libraries
WordPress plugins
Programming languages
Font scripts
Hosting
Blogs
Marketing automation
JavaScript libraries
Frequently asked questions
4.8
40,000 users



